Q2 2025 Earnings Call Transcript July 29, 2025 Stellantis N.V. misses on earnings expectations. Reported EPS is $0.2116 EPS, expectations were $0.4198. Operator: Hello, and welcome to Stellantis Half ...

In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...

Starbucks' strict RTO mandate highlights the coffee giant's culture shift under its new CEO, employees told Business Insider.

Abstract Summary Pharmacological enhancement of endoplasmic reticulum (ER) proteostasis is an attractive strategy to mitigate pathology linked to etiologically-diverse protein misfolding diseases.

Amazon's new performance review system incorporates its leadership principles, as CEO Andy Jassy looks to strengthen company culture and discipline.

Aiming T-cell engagers at autoimmune diseases continues to be a red-hot dealmaking target, as evidenced by Otsuka Pharmaceutical’s decision to pay $47 million upfront for the ex-China rights to ...

Treating types of cancer with CAR T-cell therapy is expensive and inconvenient, but a streamlined approach that creates the therapy within the body could make the intervention cheaper and easier ...

Celltrio closes $15 million funding round to expand automated cell culture and gene therapy solutions across North America and globally.

RFK Jr.'s admission raises new concerns about a possible upcoming wave of reckless stem cell deregulation from this administration.

A Gilead Sciences-backed therapy made with a patient's own white blood cells shrank tumors in 62% of patients with recurrent glioblastoma, a rare event for a fatal brain cancer with few treatment ...